Exploration of biomarkers for total fish intake in pregnant Norwegian women by Brantsæter, Anne Lise et al.
Public Health Nutrition: 13(1), 54–62 doi:10.1017/S1368980009005904
Exploration of biomarkers for total fish intake in pregnant
Norwegian women
Anne Lise Brantsæter1,*, Margaretha Haugen1, Yngvar Thomassen2, Dag G Ellingsen2,
Trond A Ydersbond3, Tor-Arne Hagve4,5, Jan Alexander1 and Helle Margrete Meltzer1
1Division of Environmental Medicine, Department of Food Safety and Nutrition, Norwegian Institute of Public
Health, PO Box 4404 Nydalen, NO-04030 Oslo, Norway: 2National Institute of Occupational Health, Oslo,
Norway: 3Statistics Norway, Oslo, Norway: 4Department of Medical Biochemistry, Rikshospitalet University
Hospital, Oslo, Norway: 5Faculty Division Akershus University Hospital, University of Oslo, Oslo, Norway
Submitted 4 April 2008: Accepted 4 March 2009: First published online 3 June 2009
Abstract
Objective: Few biomarkers for dietary intake of various food groups have been
established. The aim of the present study was to explore whether selenium (Se),
iodine, mercury (Hg) or arsenic may serve as a biomarker for total fish and seafood
intake in addition to the traditionally used n-3 fatty acids EPA and DHA.
Design: Intake of fish and seafood estimated by an FFQ was compared with intake
assessed by a 4d weighed food diary and with biomarkers in blood and urine.
Setting: Validation study in the Norwegian Mother and Child Cohort Study (MoBa).
Subjects: One hundred and nineteen women.
Results: Total fish/seafood intake (median 39 g/d) calculated with the MoBa FFQ
was comparable to intake calculated by the food diary (median 30 g/d, rS5 0?37,
P, 0?001). Erythrocyte DHA and blood Hg, Se and arsenic concentrations were
positively correlated with intake of fish and seafood, but the association for DHA
was weakened by the widespread use of supplements. The main finding was the
consistent positive association between the intake of fish/seafood and blood
arsenic concentration. In multivariate analyses, blood arsenic was associated with
blood Hg and fish and seafood intake. In these models, arsenic turned out to be
the best indicator of intake of fish and seafood, both totally and in subgroups of
fish/seafood intake.
Conclusions: While DHA reflected the intake of fatty fish and n-3 PUFA supple-
ments, blood arsenic concentration also reflected the intake of lean fish
and seafood. Blood arsenic appears to be a useful biomarker for total fish and
seafood intake.
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Assessing trends in eating habits and dietary patterns is an
essential component in the surveillance of population
health and the development of dietary advice and inter-
ventions. Dietary monitoring requires a tool validated in
the target population, and biomarkers of dietary exposure
may assist in uncovering the errors associated with the
method in use(1). For a biomarker to be used for valida-
tion of a dietary instrument, it should have a strong direct
and independent relationship with the nutrient or food
group of interest. Recovery biomarkers, like doubly
labelled water(2) and urinary N(3), are less influenced by
the body’s homeostatic control than concentration bio-
markers, which are extensively used in spite of their
weaker association with consumption(4).
Biomarkers that reflect the intake of a food group
rather than a specific nutrient are scarce. Plasma car-
otenoids and urinary flavonoids have been used as bio-
markers of fruit and vegetable groups(5,6) and plasma or
tissue n-3 PUFA, mainly EPA and DHA, have been used as
biomarkers of both total fish and fatty fish intake(7,8).
However, as lean or semi-lean fish and seafood comprise
nearly two-thirds of the total fish intake in Norway(9), a
biomarker related to total fish/seafood intake rather
than fatty fish and fish-oil supplements could contribute
to better validation of this food group than EPA or DHA.
Dietary fish and seafood are rich sources of the
essential trace elements iodine and Se, but are also a
major source of methylmercury and arsenic(10,11). The
presence of methylmercury in human tissues has been
shown to be directly related to intake of fish and sea-
food(10), whereas the relationship between blood arsenic,
blood Se and intake of fish and seafood has been inves-
tigated less. Arsenic in fish and seafood is predominantly
present in the organic form arsenobetaine. Organic forms
of arsenic are considered non-toxic compared with
inorganic arsenic from airborne industrial emissions and
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in drinking water(12). In Norway, arsenic levels in drink-
ing water are negligible (,0?2mg/l). Fish and seafood are
good natural sources of iodine, but other food groups
have been identified as more important contributors to
dietary iodine in some countries(13–15).
Monitoring the dietary intake of foods like fish and
seafood is complex in large population surveys and often
relies on the use of an FFQ, whereas biological measures
are possible only in smaller population groups. Fish and
seafood intake during pregnancy is of particular interest
owing to the potential positive impact of this food group
on birth weight and neurodevelopment of the child(16–18).
The Norwegian Mother and Child Cohort Study
(MoBa), conducted at the Norwegian Institute of Public
Health, is a large pregnancy cohort aiming to include
110 000 pregnancies by the end of 2008(19). The aim of the
present study was to compare fish and seafood intake
assessed by the MoBa FFQ with intake assessed by a 4 d
weighed food diary, and to explore how Se, iodine, Hg
and arsenic compare with the traditionally used n-3 fatty
acids EPA and DHA as biomarkers for total fish and
seafood intake.
Experimental methods
Validation study subjects and design
The present study was part of a validation study of a new
FFQ developed for use in the MoBa study(20). Other
results of the validation study have been published else-
where(21). Healthy pregnant women in MoBa referred to
Bærum Hospital (Norway) were invited to participate
in the validation study when they came for routine
ultrasound examination at 17–18 weeks of gestation.
Exclusion criteria were hyperemesis and anorexia. Before
inclusion, subjects had to have completed the MoBa FFQ.
The inclusion period lasted from 15 January 2003 to
1 February 2004.
Participants were asked to keep a 4 d weighed food
diary (FD) and to provide one 24 h urine collection and a
blood sample. Age, self-reported height and weight were
recorded. Data pertaining to smoking and education were
collected from a separate MoBa questionnaire in which
participants answered questions related to lifestyle and
demographic factors. Of 120 subjects included, one
dropped out due to illness. The average time interval
between completion of the FFQ and participation in the
study was 24 (SD 12) d. The study protocol was approved
by the Regional Ethics Committee of Southern Norway,
and informed written consent was obtained from all
participants in the validation study.
The FFQ
The MoBa FFQ (available at http://www.fhi.no/dav/
22CA50E0D7.pdf) was mailed to all participants around
the 15th week of gestation. It is a semi-quantitative
questionnaire designed to capture dietary habits and
intake of dietary supplements during the first four months
of pregnancy. The FFQ includes questions about the
intake of 255 food items including ten questions about
cold cuts and spreads made of fish/shellfish, sixteen ques-
tions about fish/shellfish eaten for dinner, and four ques-
tions about cod-liver oil/fish oil/n-3 supplement use.
The questionnaires were optically read. Consumption
frequencies were converted into food amounts (g/d) by the
use of standard Norwegian portion sizes. FoodCalc(22) and
the Norwegian food composition table(23) were used for
calculating nutrients from food. A database containing details
of the declared content of supplements was developed for
the calculation of nutrients from dietary supplements(24).
4d weighed food diary
Participants were asked to weigh and record all foods,
beverages and dietary supplements consumed during
three consecutive weekdays and one weekend day. Each
participant was given an FD and a digital balance, and
asked to continue with their normal food intake. Each
completed FD was checked for completeness of
description by the project nutritionist (A.L.B.).
Blood sampling
Non-fasting blood samples were drawn by venepuncture at
the time of recruitment into Vacutainers intended for trace
element measurement (Becton and Dickinson, Plymouth,
UK). After collection, the blood tubes were inverted to
ensure complete mixing of the anticoagulant. Samples were
stored at2708C within 2h of venepuncture. Erythrocytes for
lipid measurements were isolated by centrifugation for
10min at 250g, washed with 0?9% (w/v) NaCl, resuspended
in NaCl and stored at 2708C until analysis.
24h urinary collection
At the end of the FD period, each participant provided one
24h urine collection taken on a weekday. On the first
morning of the urine collection, participants were asked to
discard their first urine specimen and to collect all speci-
mens for the next 24h. Participants were provided with a
funnel and bottles. All urine was pooled for each participant
and the samples stored at 2208C within 8h of collection.
Analysis of biomarkers
Blood concentrations of arsenic, Se and Hg were deter-
mined by inductively coupled plasma–sector field mass
spectrometry using an Element 2 mass spectrometer
(Thermo Electron, Bremen, Germany) following pre-
viously described methods(25). In short, 1?5ml of 65%
(w/v) ultrapure nitric acid was added to 1ml of whole
blood in a polypropylene digestion tube and then heated
to 958C for 1 h. After cooling, an internal standard solu-
tion (containing 205Tl for 200,201,202Hg; 72Ge for 75As and
77,78,82Se) was added to the digested blood sample before
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dilution to volume (14ml). The instrument was calibrated
with whole blood matrix matched standard solution and
the accuracy was determined by use of Seronorm Trace
Elements human whole blood quality control samples
(Sero Ltd, Asker, Norway). The measured values for
arsenic, Se and Hg were on average within 65% of the
recommended values supported by the producer. The
within-assay precision was typically 3–5%.
Urinary concentration of iodine was determined by
inductively coupled plasma–mass spectrometry (Agilent
Quadrupole 7500c mass spectrometer; Agilent Technol-
ogies, Santa Clara, CA, USA)(26).
For analysis of the fatty acid pattern in erythrocytes,
approximately 43 109 cells were used. Erythrocyte lipids
were extracted by the method of Folch et al.(27). The
phospholipid fraction was separated from neutral lipids
using bonded silica gel columns (Analytical International,
Harbor City, CA, USA) by sequential elution with CHCl3
and MeOH(28). It was then transmethylated(29) and ana-
lysed by GC using an SP-2340 capillary column on a
Hewlett-Packard 5880A gas chromatograph (Palo Alto,
CA, USA) equipped with a flame-ionization detector, with
Ar as the carrier gas. The oven temperature was main-
tained at 1408C for 10min and then increased by 38C/min
up to 2508C. The fatty acids were identified by comparing
retention times with authentic standards. The fatty acid
pattern in erythrocyte phospholipids was not obtained in
twenty-five subjects owing to technical problems in the
fatty acid analysis and insufficient amounts of samples for
re-analysis.
Statistical analysis
The differences between food intakes calculated by the
FFQ and the FD were tested with the Wilcoxon signed rank
test (paired data) and the differences between groups were
tested using the Mann–Whitney U test (unpaired data). The
linear trend in blood arsenic, Se and Hg, urinary iodine
excretion, erythrocyte EPA and erythrocyte DHA with fish
and seafood intake was assessed by regression.
The FFQ and the FD may be considered as two inde-
pendent, unbiased methods for assessing dietary intake
and therefore their estimation errors may be expected to
partially cancel out, making their average a better esti-
mate of true intake than either. As the averages provided
better model fits, they were used in subsequent analyses.
For analysis of the association between blood and
urine data and indicators of fish intake, fish spread and
fatty fish were aggregated into one variable (as fish
spreads are mainly fatty fish) and, likewise, lean fish and
processed fish foods were aggregated.
The associations between the parameters were ana-
lysed by multiple regression. The dependent variables
were transformed to the power giving best model fits
and, in order to compare coefficients as easily as possible,
they were ‘standardized’ to a mean of 1. When several
explanatory variables were used in a model, they were
transformed to make an independent set. The basic
assumption of ordinary regression analysis – that for every
combination of the explanatory variables, the dependent
variable follows distributions with the same variance – was
in no case shown to be false. Only covariates significantly
different from zero were retained in the models.
Regression coefficients from standardized models are
reported, as well as adjusted correlation coefficients
describing total model fit.
The significance level was set at 5% (two-tailed) and all
analyses were performed using the SPSS statistical soft-
ware package version 14 (SPSS Inc., Chicago, IL, USA).
Results
Among the 119 participants in the study, there was large
dispersion with regard to age, BMI, education, parity and
smoking status (Table 1). Mean daily total fish and sea-
food intake was 42 g (median 39 g) by the FFQ, 37 g
(median 30 g) by the FD and 40 g (median 38 g) as an
average of the two methods. Processed fish, i.e. fish in
fish fingers, fish burgers, fish pudding and fish au gratin,
was the largest contributor to total fish intake (Table 2).
Intakes calculated by the two dietary methods correlated
significantly for fish used for sandwich spread (fish
spread), tuna, shellfish and total fish/seafood intake
(Table 2). Three participants (2?5%) reported no intake of
fish or seafood in the FFQ and twenty-one participants
(17?6%) reported no intake of fish and seafood in the FD.
One subject with extremely high blood arsenic con-
centration (.6 SD above the 95th percentile) was exclu-
ded from analyses regarding arsenic. The mean, median
and range indicator values of biomarkers of the different
nutrients in all participants and supplement non-users are
presented in Table 3.
Use of dietary supplements containing Se was reported
by twenty-seven women in the FFQ and by thirty women
in the FD. No statistical difference was found in blood Se
between users and non-users of Se supplements. Iodine-
containing supplement use was reported by twenty-three
women in the FFQ and by twenty-five women in the FD.
Urinary iodine excretion was twice as high in participants
taking an iodine-containing dietary supplement (median
at time of the FD: 220mg/24 h) than in non-users of iodine
supplements (median: 110mg/24 h, P5 0?001).
Use of EPA- and DHA-containing supplements was
reported by eighty-two women in the FFQ and by seventy-
nine in the FD, whereas twenty-nine women had not taken
any supplements containing n-3. The sum of erythrocyte
n-3 fatty acids differed significantly between users and non-
users of n-3 supplements (P,0?001), but not erythrocyte
DHA and EPA alone. Erythrocyte membrane EPA (% of fatty
acids) did not correlate with dietary EPA (diet and supple-
ments), whereas erythrocyte membrane DHA (% of fatty
acids) correlated significantly with dietary DHA estimated
56 AL Brantsæter et al.
by the FFQ (r50?25, P50?014), the FD (r50?24, P5
0?018) and the average (r50?28, P50?006).
Cod-liver oil is the most common vehicle for n-3 fatty
acids in food supplements in Norway. Thus this oil might
also serve as a vehicle for the non-essential elements
under investigation in the present survey. We lack data for
the arsenic and Hg content of cod-liver oil but personal
communication from the main Norwegian producer
(M +oller’s) indicated that the concentrations are very low,
and there was no difference in blood values between
supplement users and non-users when it came to these
two elements.
Women who were daily smokers in pregnancy (n 3)
had lower blood Se concentration (median 77mg/l) than
non-smokers (median 106mg/l, P5 0?001) and lower
blood arsenic concentration (median 0?80mg/l in smokers
and 1?80mg/l in non-smokers, P5 0?023). Blood Se was
positively correlated with age (r5 0?31). Furthermore,
there was a positive association between blood Se and Hg
and education level. We found no differences in the
intake of fish and seafood between the women with
regard to smoking status or education, but the total intake
of fish/seafood increased with increasing age (average of
FFQ and FD v. age: r5 0?29, P5 0?003).
Three women who reported no intake of fish or seafood
in the FFQ and twenty-one women who reported no intake
of fish or seafood in the FD had significantly lower blood
arsenic and Hg concentrations than women who reported
intake of this food group (PFFQ5 0?003 for arsenic and
PFFQ5 0?019 for Hg, PFD, 0?001 for arsenic and PFD5
0?008 for Hg). However, the only significant difference
between fish-eaters and non-eaters for blood Se, urinary
iodine excretion or erythrocyte EPA or DHA was in ery-
throcyte DHA when n-3 dietary supplement users were
excluded. There was no significant positive correlation
between fish/seafood intake and erythrocyte EPA.
Blood arsenic was correlated with blood Se (r5 0?25,
P, 0?005) and blood Hg (r5 0?44, P, 1?03 1025), and
blood Se and Hg were correlated (r5 0?28, P, 0?003).
However, the associations with Se lost significance when
adjusting for intake of fish and seafood, whereas the
arsenic–Hg relationship persisted (r5 0?34, P, 0?0002).
No other factors were significantly associated with blood
arsenic when entered into models together with fish/
seafood intake and blood Hg.
There was no correlation between lean and fatty fish
intake in the population studied. In multivariate analyses,
total fish/seafood intake and blood Hg (adjusted for
fish/seafood intake) emerged as the variables most
closely associated with blood arsenic, together covering
about 22% of the variation in blood arsenic (Table 4).
The association was non-linear in arsenic, having the
equation:
½Arsenic0.5 ¼ 0.74þ 0.26ð0.06Þ  fish=seafood
þ 0.21ð0.05Þ  ½Hgadj
(adjusted R25 0?22, P, 2?03 1027; P (coefficient for
fish/seafood5 0)5 1?23 1025).
Table 1 Demographic and lifestyle information of validation study participants: subset of pregnant women (n 119) in the Norwegian Mother
and Child Cohort Study (MoBa)
Summary statistic
Factor Mean SD Min, max
Age (years) 31?2 4?1 23, 44
BMI prior to pregnancy (kg/m2) 23?2 3?6 17, 43
BMI at time of validation study (kg/m2) 24?8 3?5 18, 41
No. of weeks pregnant- when filling in the FFQ 17 2
No. of weeks pregnant- when entering validation study 20 2
n %
Nausea at time of filling in the FFQ 18 15
Parity
0 66 55
1 25 21
21 28 24
Education (highest level completed)
#12 years 20 17
13–16 years 58 49
.16 years 41 34
Smoking status in pregnancy
Daily 3 3
Occasionally 0
Non-smoker 116 97
Dietary supplement use at time of the FFQ or FD
Se 39 33
Iodine 25 21
n-3 fatty acids 90 76
FD, 4 d weighed food diary.
-No. of weeks pregnant calculated based on days since date of last menstruation.
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In the regression models Hg and Se were significantly
correlated with tuna and lean/processed fish, DHA was
significantly correlated with spread/fatty fish and lean/
processed fish, whereas arsenic was significantly (or
nearly significantly) correlated with all items (Table 4).
Figure 1 demonstrates how the daily intakes of the
separate fish/seafood items as well as total fish/seafood
(average of the FFQ and FD) are related to blood arsenic
(n 118). Figure 2 illustrates the differences between n-3
supplement users and non-users regarding the association
between erythrocyte DHA and fish/seafood intake: the
association, as measured by the slopes of the regression
lines, is attenuated by the use of supplements (P50?002,
P50?368 and P50?005 for zero slope in supplement non-
users, supplement users and the whole group, respectively).
Discussion
In the current study we first compared the intakes of fish
and seafood calculated by a new FFQ with intakes cal-
culated by a weighed food diary, and then examined the
association between the FFQ and FD intakes of fish and
seafood with potential biomarkers in blood and urine.
The intakes of the different items of fish and seafood
calculated with the new FFQ were confirmed by the
intakes recorded in the food diary. Within the methods’
limits of precision, the results may be considered a vali-
dation of the FFQ for fish and seafood intake. Our main
finding was the positive association between the intake of
fish and seafood and blood arsenic concentration in all
fish/seafood categories and irrespective of the fatty acid
content of the fish (Table 4). This indicates that blood
arsenic may be a useful biomarker for short- and medium-
term fish and seafood intake.
The average fish consumption in our study population
(40 g/d, Table 2) was larger than that reported in pregnant
women in Denmark (27 g/d)(30) and Mexico (32 g/d)(31),
but lower than that reported in pregnant Icelandic
women (47 g/d)(16). In general, young women have the
lowest fish consumption in Norway and, in agreement
with previous studies, we found that approximately two-
thirds of the ingested fish and seafood was lean or semi-
lean species(9).
Biomarkers reflect actual rather than reported intakes
and are thus unaffected by respondents’ reporting bias,
typical of diet records and recalls(32). The most frequently
used biomarkers for intake of fish are the marine n-3 fatty
acids EPA (20 : 5n-3) and DHA (22 : 6n-3) in adipose
tissue, plasma or erythrocytes(8,33,34). They reflect fatty
fish ingestion and intake of fish-liver oil and other
n-3-containing supplements(34). In Norway, there is a
high frequency of cod-liver oil/fish-oil supplement
use(35,36). Most fish consumers eat a mixture of lean and
fatty fish, making EPA/DHA fairly good biomarkers in
subjects not taking n-3 supplements; however, for theT
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reasons mentioned, they cannot be considered very
robust indicators.
In our subjects, erythrocyte DHA, but not EPA, con-
centration was significantly associated with the total
intake of fish/seafood. The association was significant in
the whole group, but was far stronger in the subjects
not taking n-3-containing supplements (Fig. 2). We have
previously reported a significant positive correlation
Table 4 Coefficients in regression models with all variables standardized to unit means, describing the association between the potential
biomarkers and total fish/seafood intake and separate items of fish/seafood intake: subset of pregnant women (n 118 for arsenic, Hg and
Se; n 94 for DHA) in the Norwegian Mother and Child Cohort Study (MoBa)
Total fish/seafood Tuna Spread/fatty fish Lean/processed Shellfish
Biomarker b SE Adj. R2 b SE Adj. R2 b SE Adj. R2 b SE Adj. R2 b SE Adj. R2
Blood arsenic0?5 0?26*** 0?06 0?22- 0?03* 0?02 0?12- 0?07(*) 0?04 0?11 0?17*** 0?05 0?18- 0?05* 0?02 0?12
Blood Hg 0?36*** 0?10 0?15-
-
0?09*** 0?02 0?15-
-
0?05 0?06 0?05 0?25** 0?08 0?12-
-
0?08(*) 0?04 0?07
Blood Se 0?12*** 0?04 0?15-
-
0?02* 0?01 0?08-
-
0?05* 0?02 0?08 0?08** 0?02 0?11-
-
0?00 0?01 0?03
DHA 0?11** 0?03 0?08-
-
0?01 0?01 0?02-
-
0?05* 0?02 0?05 0?06* 0?03 0?05-
-
0?00 0?03 0?01
( *) 0?05,P, 0?06, *P, 0?05, **P, 0?01, ***P, 0?001.
-Model includes fish item and blood Hg adjusted for total fish/seafood intake.
-
-
Model includes fish item and categories of maternal education.
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Fig. 1 Median and 75th percentile (P75) daily intake (g/d) of
tuna (&), shellfish (’), fish spread/fatty fish ( ), lean/
processed fish ( ) and total fish/seafood ( ) by quintile of
blood arsenic concentration. Intake estimates are calculated
as the average of FFQ and food diary consumption data
among a subset of pregnant women (n 118) in the Norwegian
Mother and Child Cohort Study (MoBa)
Table 3 Summary statistics for biomarkers of the different nutrients, in all participants and supplement non-users: subset of pregnant
women (n 119) in the Norwegian Mother and Child Cohort Study (MoBa)
All Supplement non-users only
Biomarker n Mean SD Median P5, P95 n Mean SD Median P5, P95
Erythrocyte membrane DHA (% of fatty acids) 94- 9?0 1?9 9?2 5?8, 11?5 24 8?6 2?6 8?2 6?3, 10?6
Erythrocyte membrane EPA (% of fatty acids) 94- 1?7 1?3 1?7 0, 3?7 24 1?3 1?5 0 0, 3?5
Urinary iodine excretion (mg/24 h) 119 161 97 131 44, 365 84 140 90 110 44, 321
Blood Se (mg/l) 119 107 21?4 106 77?0, 141 80 106 20?7 106 74?0, 135?2
Blood Hg (mg/l) 119 1?88 1?21 1?67 0?32, 4?30
Blood arsenic (mg/l) 118-
-
2?57 2?19 1?78 0?80, 7?24
P5, 5th percentile; P95, 95th percentile.
-Erythrocyte fatty acid results available for ninety-four subjects only.
-
-
One outlier excluded.
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Fig. 2 Impact of fish and seafood intake on erythrocyte DHA in
n-3 supplement users (– –J– –; r2 linear50?014) and non-
users (—m—; r2 linear5 0?342) among a subset of pregnant
women (n 118) in the Norwegian Mother and Child Cohort
Study (MoBa)
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between the erythrocyte membrane phospholipid n-6:n-3
fatty acid ratio and dietary n-6:n-3 fatty acid ratio(24).
Williams et al. found a strong positive correlation for
frequency of fish consumption in early pregnancy with
both erythrocyte DHA and EPA(37), whereas Parra et al.,
like us, found a significant positive association between
dietary intake and erythrocyte DHA, but not EPA(31).
Matorras et al. found no association between dietary
intake and erythrocyte membrane fatty acids(38). During
pregnancy, there is a faster turnover of fat storage that
may modify the profile of erythrocyte n-3 fatty acids and
lower the correlation between dietary intake and ery-
throcyte n-3 fatty acids(31). It has been suggested that EPA
is under different homeostatic and metabolic control than
DHA(34). The percentage of DHA in erythrocyte mem-
branes is quantitatively much larger than EPA, and during
pregnancy the conversion of EPA to DHA is given prior-
ity(39). The present study is in accordance with previous
studies in that the relationship between fish consumption
and serum/tissue DHA applies primarily to intake of fatty
fish and n-3 supplements(34,40,41).
When total intake of milk and other dairy products,
containing iodine from mandatory fodder fortifica-
tion(14,42), was included as a covariate, no fish variables
were significantly associated with urinary iodine excre-
tion(43). Urinary iodine excretion is therefore not suitable
as a biomarker for fish and seafood intake in Norwegians.
While fish and shellfish is the main dietary source of
Hg, dietary sources of Se also include eggs, cereals and
meat(44). Several investigators have evaluated self-reports
of fish intake with blood concentrations of Hg and Se in
women of childbearing age(45–48). Bates et al. studied the
contribution of fish and other foods to variance of Se and
Hg status in British adults and concluded that dietary fish,
especially oily fish, was a strong predictor of blood Hg
and Se in this population(47). Bjornberg et al. found an
increase in blood Hg, but not in Se, with increasing fish
consumption in pregnant Swedish women(48).
Pregnant women have been shown to have lower
consumption of certain fish species owing to concerns
about Hg contamination(49). In Norway, pregnant women
are advised to limit the intake of large perch, wild trout
and halibut and to not eat pike, fish liver or exotic pre-
datory fish like fresh tuna. Canned tuna is considered
safe(50), although reports show that Hg concentrations
here may also vary considerably(51,52). In spite of the
relatively low intake of tuna (Table 2), this food item
was significantly associated with blood Hg (Table 4). All
tuna reported in the present study was in the form of
canned tuna or tuna products used as sandwich spread.
The overall low blood Hg levels in our subjects indicate
that pregnant Norwegian women do not, generally, need
to be more careful about their Hg intake than they
are already.
Few studies have examined the association between
fish consumption and blood arsenic concentration(53–55).
We found a positive association between blood arsenic
concentration and intake of fish and seafood, but it may
be asked whether this could be due to interactions with
other elements, such as Hg and Se, as these are also
associated with fish/seafood intake. Our data indicate an
independent role of arsenic for fish and seafood intake.
Arsenobetaine in fish is absorbed and rapidly eliminated
via the urine(12). Volunteers who ingested arsenobetaine
through seafood eliminated 70% of the arsenic within the
first two days and 77% within 8 d of ingestion, and in
volunteers who ingested radioactively labelled arseno-
betaine with fish, ,1% of the ingested activity remained
in the body after 24 d(55). The effect of fish arsenic on
blood arsenic has, to our knowledge, been reported in
only one study. In a semi-controlled feeding study,
Meltzer et al. found a strong positive correlation (r5 0?85,
P, 0?001) between dietary arsenic from fish (estimated
by analysis) and blood arsenic concentration and
between total grams of fish and blood arsenic con-
centration (r5 0?41, P, 0?02)(54).
The rapid excretion might make blood arsenic a good
biomarker for short-term fish intake only, but our results
strongly indicate that arsenic might also be associated
with medium-term fish/seafood intake. Furthermore, the
independent association with Hg might indicate a similar
association with long-term intake not reflected in the
dietary assessment. Fish and seafood may be assumed to
be the most important contributor to the Hg load in these
women, with blood Hg partially reflecting historical
fish/seafood ingestion. To our knowledge, no specific
Hg–arsenic interactions have been described to account
for the observed association, so it might indicate historical
intake of a common source of Hg and arsenic. For blood
arsenic to be established as a biomarker for fish and
seafood intake, detailed short- and medium-term studies
are necessary.
The associations between the potential biomarkers
and various subgroups of fish and seafood intake in the
present study were generally not very strong, but prob-
ably close to what might be expected. The physiological
and metabolic changes related to pregnancy may have
attenuated some associations, but apart from possibly the
fatty acids, we have no indications that the results would
have been substantially different with non-pregnant
women. As opposed to Se, iodine and EPA/DHA, blood
arsenic will normally be minimally influenced by the use
of dietary supplements. Another advantage of blood
arsenic over the n-3 fatty acids as a biomarker for intake
of seafood is the ability to reflect total fish and seafood
intake independent of the fat content of ingested fish.
Blood arsenic is, however, not applicable as a biomarker
for fish intake in areas with high arsenic load from the
drinking water.
Exploration of Se, iodine, Hg, n-3 fatty acids and
arsenic as potential biomarkers of fish and seafood intake
showed that blood arsenic concentration appears to be
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a robust potential biomarker for fish and seafood intake.
Blood arsenic concentration reflected the intake of both
fatty and lean fish and seafood in this population of
pregnant women, and it is not influenced by dietary
supplement use and fat content of the ingested fish, as the
n-3 fatty acids are. More studies need to be carried out to
confirm the results obtained.
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